Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials and soft tissue sarcomas.

Ashwani Rajput1, William G Kraybill

  • 1Roswell Park Cancer Institute, Department of Surgery, State University of New York at Buffalo, NY, USA.

Surgical Oncology Clinics of North America
|August 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.

JAMA oncology·2023
Same author

Colorectal Cancer Survivors' Receptivity toward Genomic Testing and Targeted Use of Non-Steroidal Anti-Inflammatory Drugs to Prevent Cancer Recurrence.

Journal of community genetics·2022
Same author

EGFR transactivates RON to drive oncogenic crosstalk.

eLife·2021
Same author

The Impact of Surgical Delays on Short- and Long-Term Survival Among Colon Cancer Patients.

The American surgeon·2021
Same author

Operative Approach Does Not Impact Radial Margin Positivity in Distal Rectal Cancer.

World journal of surgery·2021
Same author

Impact of Treatment Coordination on Overall Survival in Rectal Cancer.

Clinical colorectal cancer·2021

Advancements in soft tissue sarcoma treatment include limb-sparing surgery and multimodal therapies. New targeted drugs like STI-571 show promise, highlighting the need for collaborative clinical trials to improve patient outcomes.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Soft tissue sarcomas are diverse and challenging cancers affecting various body sites.
  • Treatment has evolved from radical amputations to limb-sparing procedures and multimodal strategies.
  • Progress in understanding sarcoma biology is crucial for developing novel therapeutic interventions.

Purpose of the Study:

  • To review the progress in managing soft tissue sarcomas.
  • To highlight the impact of targeted therapies, such as STI-571 in GIST, as a potential new treatment paradigm.
  • To emphasize the importance of collaboration in clinical trials for rare tumors.

Main Methods:

  • Review of current treatment modalities for soft tissue sarcomas.
  • Discussion of emerging targeted therapies and their implications.

Related Experiment Videos

  • Emphasis on cooperative group efforts and clinical trial enrollment.

    • Main Results:

    • Significant progress has been made in local control rates through multimodality treatment.
    • Limb-sparing procedures have largely replaced radical amputations.
    • The development of STI-571 demonstrates the potential of targeted therapy in specific sarcomas (GIST).

    Conclusions:

    • Continued research into sarcoma biology will drive new treatment strategies.
    • Targeted therapies represent a promising frontier for sarcoma treatment.
    • Collaborative clinical trials are essential for advancing the care of patients with rare, low-incidence tumors like soft tissue sarcomas.